MarketPR
The proposed combination of pharmacy benefit managers Abarca Health and LucyRx is drawing attention beyond the two companies involved, with analysts and industry observers flagging it as a potential catalyst for further mergers and acquisitions across the PBM sector.
The deal signals that consolidation pressure in pharmacy benefit management has not abated, and that smaller players may face mounting incentives to find partners of their own.
A Deal That Signals Sector Stress Pharmacy benefit managers occupy a critical position in the U.S. drug supply chain, sitting between insurers, employers, and pharmacies to negotiate drug pricing and manage formularies.
The Abarca-LucyRx tie-up suggests that even mid-sized PBMs are reassessing their standalone viability.
Keep reading